Skip to main content
. 2021 May 26;8:626328. doi: 10.3389/fmolb.2021.626328

FIGURE 5.

FIGURE 5

BARX1 and DLX4 predict poor prognosis in ccRCC and may promote epithelial–mesenchymal transition (EMT). (A) In the TCGA KIRC cohort, BARX1 and DLX4 highly expressed patients have poorer disease-specific survival (DSS). (B) In the TCGA KIRC cohort, BARX1 and DLX4 highly expressed patients have poorer overall survival (OS). (C) The prognostic nomogram of BARX1 or DLX4 for OS at 1, 3, and 5 years. (D) The gene set enrichment analysis (GSEA) of hallmark gene sets in the high-expression group of BARX1 or DLX4.